Uterine wall medicine applying equipment
By designing uterine wall application equipment including shell, expansion assembly and drug-administered assembly, the existing equipment has poor comfort and uneven agents during drug application, and efficient and safe drug application effect has been achieved.
Patent Information
- Application Number
- CN202411932105.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-12-26
- Publication Date
- 2025-03-14
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The existing uterine wall application equipment has poor comfort during the application process, the agent is uneven, and it is difficult to meet the drug application needs of liquid and solid drugs at the same time, increasing labor consumption and equipment costs.
A uterine wall application device including a shell, an expansion assembly and a drug-administered assembly is designed to open the vagina and cervix through the expansion assembly, and use solid and liquid drug delivery devices to achieve uniform application and safe application of drugs.
It improves the comfort of the medication process and the uniformity of the medication, reduces the risk of damage to the uterus, reduces manpower consumption and equipment costs, and can meet the medication needs of liquid and solid medications at the same time.
Smart Images

Figure CN119607389A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of medicine coating equipment, in particular to a uterine wall medicine coating equipment. Background Art
[0002] In real life, applying medication inside the body has always been an embarrassing task in gynecology, because the area where medication is applied is relatively private, and the existing medication application method mainly uses manual delivery. Therefore, it is difficult for patients who have not received professional training to apply medication by themselves. Therefore, patients usually need the help of doctors or nurses to apply medication. Most of the existing medication application equipment has the disadvantages of poor comfort during the medication application process and uneven application of the medication.
[0003] The prior art also proposes some solutions: For example, a patent application with the publication number CN113332579A discloses a gynecological uterine wall medicine coating device: including a mounting shell and a protective plate, the protective plates are provided on both the front and rear sides of the right outer wall of the mounting shell; a nozzle, the nozzle is provided on the left side of the mounting shell. The present invention is provided with an injection mechanism, the injection mechanism cooperates with the extrusion mechanism, the extrusion mechanism can control the injection mechanism to spray the medicine, thereby effectively saving manpower consumption in the medicine coating process; the infusion mechanism cooperates with the injection mechanism, the infusion mechanism can transport the medicine into the injection mechanism, thereby greatly improving the convenience of medicine coating.
[0004] In order to ensure more hygienic use and avoid cross infection, most of the internal medication application devices in the prior art are disposable. Since the medication applied to the inside of the uterus may be liquid medicine or solid particles, if the patient needs to use different types of medicines at the same time, one medication application device cannot meet the demand. If multiple medication application devices are used, it will increase the cost and the repeated use of medication application tools will reduce the patient's comfort. Moreover, if the medication application method is used, the medication application device will come into contact with the inner wall of the uterus. The thickness of the inner wall of the uterus will vary depending on the individual's physical condition. It is impossible to control the strength of the medication application, which can easily cause great harm to the patient.
[0005] To this end: the present invention provides a uterine wall medicine coating device. Summary of the invention
[0006] In order to make up for the deficiencies of the prior art, at least one technical problem raised in the background technology is solved.
[0007] The technical solution adopted by the present invention to solve the technical problem is as follows: a uterine wall medicine applying device according to the present invention comprises a shell, an expansion component and a medicine applying component, wherein the shell is located between the expansion component and the medicine applying component, the expansion component is located in the middle section of the medicine applying device, the medicine applying component is located at the rear end of the medicine applying device, and the medicine applying component comprises a solid medicine delivering device and a liquid medicine delivering device; a gripping member is fixedly connected between the outer wall of the shell and the outer wall of the liquid medicine delivering device; The shell is an important component connecting the entire device. When the patient uses the medication application device, the device will first be inserted into the body. When it reaches the appropriate depth, the expansion component will be used to expand the vaginal wall to fully expose the vagina and cervix. This not only facilitates observation of the situation inside the uterus but also makes it easier to apply medication. At this time, the medication can be applied to the inside of the uterus through the medication application component according to the internal situation. The medication application device has both a solid drug channel and a liquid drug channel. Therefore, no matter what state of medicine the patient needs to apply, there is a corresponding structure for applying the medicine. Through the cooperation of the solid drug delivery device and the liquid drug delivery device, the effect of simultaneously satisfying the application of two different forms of drugs can be achieved.
[0008] Preferably, a probe is provided on the outer wall of the delivery tube near the front end, and the probe is formed by a plurality of plates spliced and connected, and a separation plate is slidably connected between the plates, and the outer wall of the plate and the outer wall of the expansion plate are both installed with fixing parts, and a retracting rod is hinged between the fixing parts installed on the outer wall of the expansion plate and the fixing parts installed on the outer wall of the plate, and the solid drug delivery device is located at the tail end of the drug application device and has a drug release port on its outer wall, and one end of the solid drug delivery device is fixedly connected to a drug delivery tube, and a central column is rotatably provided inside the drug delivery tube, and the outer wall of the central column is fixedly connected to The other end of the drug delivery tube is a drug outlet, a visual detector is installed at one end of the central column near the drug outlet, a fixed block is fixedly installed inside the solid drug delivery device, a power piece is fixedly connected to the inner wall of the fixed block, an auxiliary gear is fixedly connected to the output shaft of the power piece, and a power gear is fixedly connected to one end of the central column near the solid drug delivery device, and the teeth of the power gear and the teeth of the auxiliary gear are meshed with each other. When using the drug application device, the operator first holds the gripping piece, and then applies an appropriate amount of lubricant on the probe, which can In order to reduce the friction on the vaginal mucosa during the insertion process and reduce the patient's discomfort, the drug application device is then controlled to slowly enter the patient's body. At this time, the expansion plate is controlled to expand outward, the plate of the probe slides on the separation plate, and the probe is controlled by the contraction rod to expand and stretch the vaginal wall. The first to enter is the visual detector, which will feedback the situation inside the uterus to the outside world. At the same time, it can also detect the position of the probe and the inner wall of the uterus, so that it is convenient to control the insertion depth of the drug application device. When the drug application device reaches the designated position, the drug is applied according to the drug required by the patient. If the patient needs solid granular drugs, the power part is started at this time, and the drug is placed in the solid drug delivery device through the drug release port. The power part controls the assisting gear to drive the power gear to rotate. The power gear control drives the transmission part to rotate by controlling the rotation of the central column. At this time, the solid drug will be driven by the transmission part to move along the drug delivery tube until the solid drug falls from the other end of the drug delivery tube to the inside of the uterus. Through the operation of the solid drug delivery device, the solid drug is delivered to the inside of the uterus for drug application.
[0009] Preferably, the liquid medicine delivery device is located at the tail end of the medicine application device, and the outer wall of the liquid medicine delivery device is provided with a plurality of slots, and the outer wall of each slot is clamped with a medicine dish, and different types of liquid medicines are stored in the interior of each medicine dish, and a plurality of delivery tubes are installed on the outer wall of the medicine delivery tube, and different types of medicine dishes correspond to the delivery tubes of the medicines respectively, and a connecting tube is clamped between the interior of each group of medicine dishes and the outer wall of the delivery tube, and a medicine spray ring is provided on the outer wall of one end of the medicine delivery tube close to the medicine outlet, and a plurality of spray holes are provided on the outer wall of the medicine spray ring, and the outer wall of the medicine spray ring is fixedly connected to the delivery tube and is conductive to each other. If the patient needs liquid medicine The interior of the liquid medicine delivery device is equipped with medicine dishes for storing different medicines. At this time, the connecting tube sucks the medicine in the medicine dish into the delivery tube. After the medicine in the delivery tube is transferred to the other end, the medicine will enter the medicine spray ring. At this moment, the medicine spray ring rotates while spraying the internal medicine on the inner wall of the uterus through the spray port. The thickness of the inner wall of the uterus varies according to individual physical condition. If the smearing method is used, the medicine application equipment will come into contact with the inner wall of the uterus, and the force of applying the medicine cannot be controlled, which can easily cause great harm to the patient. Through the operation of the liquid medicine delivery device, it not only plays the role of applying the medicine inside the uterus, but also reduces the risk of damage to the uterus.
[0010] Preferably, the expansion component includes an expansion disk, which is located inside the shell, and the outside of the expansion disk is provided with a plurality of expansion slides and limiting slides, the expansion slides and the limiting slides are connected to each other, the inner wall of each expansion slide is slidably connected to the limiting nail, and the other end of each limiting nail is installed with an expansion plate, the outer wall of the expansion disk is provided with a wind blade, the outer wall array of the wind blade is provided with a toggle blade, and the toggle blade contacts the limiting nail, and the inner wall of each expansion plate is fixedly installed with a support frame, and the other end of the support frame is slidably connected to the outer wall of the conveying pipe, and a connecting plate is inserted and connected between the outer walls of each expansion plate, and the outer wall of the connecting plate is slidably connected to the inner wall of the expansion plate, and a probe is provided on the outer wall of the conveying pipe near the front end, and the probe is formed by splicing and clamping a plurality of plates, and a separation plate is slidably connected between the plates. The wall and the outer wall of the expansion plate are both equipped with fixings, and a retraction rod is hinged between the fixings installed on the outer wall of the expansion plate and the fixings installed on the outer wall of the plate. When the medication device enters the patient's body, the expansion component is needed to expand the vagina and cervix, and the power component controls the wind blade component to rotate. When the wind blade component rotates, the toggle blade will also rotate accordingly. When the outer wall of the toggle blade contacts the limit pin, the limit pin will be controlled by the toggle blade to slide on the expansion disk. First, the limit pin will slide on the expansion slide groove, and at this time the expansion plate will be controlled to expand outward along the trajectory of the expansion slide groove. When the limit pin slides to the limit slide groove, the limit pin will control the expansion plate to be in an expanded state. When the power component rotates in the opposite direction, the toggle blade will reversely toggle the limit pin back to the initial position along the original sliding trajectory. Through the operation of the expansion component, the effect of expanding the vagina and cervix is achieved.
[0011] The beneficial effects of the present invention are as follows: 1. The uterine wall medicine coating device described in the present invention, through the operation of the liquid medicine delivery device, not only plays the role of applying medicine to the inside of the uterus, but also reduces the risk factor of causing damage to the uterus. If the patient needs liquid medicine, the liquid medicine delivery device is equipped with a medicine dish for storing different medicines. At this time, the connecting tube sucks the medicine in the medicine dish into the delivery tube, and then the medicine in the delivery tube is transferred to the other end, and the medicine will enter the medicine spray ring. At this time, the medicine spray ring rotates while spraying the internal medicine on the inner wall of the uterus through the spray port. The thickness of the inner wall of the uterus will vary depending on the individual's physical condition. If the smearing method is used, the medicine application device will come into contact with the inner wall of the uterus, and the force when applying the medicine cannot be controlled, which can easily cause great harm to the patient.
[0012] 2. The uterine wall medicine coating device described in the present invention has the effect of stretching the vagina and cervix through the operation of the expansion component. After the medicine application device enters the patient's body, the expansion component is needed to stretch the vagina and cervix. The power part controls the wind blade part to rotate. When the wind blade part rotates, the toggle blade will also rotate accordingly. When the outer wall of the toggle blade contacts the limit pin, the limit pin will be controlled by the toggle blade to slide on the expansion disk. First, the limit pin will slide on the expansion slide groove. At this time, the expansion plate will be controlled to stretch outward along the trajectory of the expansion slide groove. When the limit pin slides to the limit slide groove, the limit pin will control the expansion plate to be in an open state. When the power part rotates in the opposite direction, the toggle blade will reversely toggle the limit pin and return to the initial position along the original sliding trajectory.
[0013] 3. The uterine wall drug coating device described in the present invention, through the operation of the solid drug delivery device, has the effect of delivering solid drugs to the inside of the uterus for drug application. The power component is started, and the drug is placed into the solid drug delivery device through the drug release port. The power component controls the assisting gear to drive the power gear to rotate. The power gear controls the rotation of the control center column to drive the transmission component to rotate. At this time, the solid drug will be driven by the transmission component to move along the drug delivery tube until the solid drug falls from the other end of the drug delivery tube into the inside of the uterus. BRIEF DESCRIPTION OF THE DRAWINGS
[0014] The present invention will be further described below in conjunction with the accompanying drawings.
[0015] Figure 1 It is an overall diagram of the present invention; Figure 2 The present invention Figure 1 The enlarged structural diagram at B in the middle; Figure 3 It is a schematic diagram of the probe structure of the present invention; Figure 4 The present invention Figure 3 The enlarged structural diagram at A in the middle; Figure 5 It is a schematic diagram of the expansion plate structure of the present invention; Figure 6 It is a schematic diagram of the expansion disk structure of the present invention; Figure 7 It is a schematic structural diagram of the liquid medicine delivery device of the present invention; Figure 8 is a schematic structural diagram of the solid drug delivery device of the present invention; Fig. 9 It is a schematic diagram of the structure of the drug delivery tube of the present invention.
[0016] In the figure: 100, shell; 101, grip; 102, probe; 103, separation plate; 104, fixing member; 105, retracting rod; 200, expansion assembly; 201, expansion disk; 202, expansion slide; 203, limit slide; 204, limit pin; 205, expansion plate; 206, fan blade; 207, shift blade; 208, support frame; 209, connecting plate; 300, medicine application assembly; 301, solid medicine delivery device; 302, medicine release port; 303, medicine delivery tube; 304, center column; 305, transmission member; 306, visual detector; 307, liquid medicine delivery device; 308, medicine dish; 309, delivery tube; 310, connecting tube; 311, medicine spray ring; 312, fixing block; 313, power member; 314, auxiliary gear; 315, power gear. DETAILED DESCRIPTION
[0017] In order to make the technical means, creative features, objectives and effects achieved by the present invention easy to understand, the present invention is further explained below in conjunction with specific implementation methods.
[0018] like Figures 1 to 9 As shown, a uterine wall medicine coating device according to an embodiment of the present invention comprises a housing 100, an expansion assembly 200 and a medicine applying assembly 300, wherein the housing 100 is located between the expansion assembly 200 and the medicine applying assembly 300, and the medicine applying assembly 300 comprises a solid medicine delivery device 301 and a liquid medicine delivery device 307; a gripping member 101 is fixedly connected between the outer wall of the housing 100 and the outer wall of the liquid medicine delivery device 307; When working, the shell 100 is an important component connecting the entire device. When the patient uses the medication device, the device will first be inserted into the body. When it reaches the appropriate depth, the expansion component 200 will be used to open the vaginal wall to fully expose the vagina and cervix. This not only facilitates the observation of the situation inside the uterus, but also makes it easier to apply medication. At this time, the medication component 300 can be used to apply medication to the inside of the uterus according to the internal situation. The medication application device has both a solid drug channel and a liquid drug channel. Therefore, no matter what state of medicine the patient needs to apply, there is a corresponding structure for applying the medicine. Through the cooperation of the solid drug delivery device 301 and the liquid drug delivery device 307, the effect of simultaneously satisfying the application of two different forms of drugs is achieved.
[0019] like Figures 8 to 9 and Figures 2 to 3 As shown, the solid medicine delivery device 301 is located at the tail end of the medicine coating device and has a medicine delivery port 302 on its outer wall. One end of the solid medicine delivery device 301 is fixedly connected to a medicine delivery tube 303. A central column 304 is rotatably arranged inside the medicine delivery tube 303. A transmission member 305 is fixedly connected to the outer wall of the central column 304. The other end of the medicine delivery tube 303 is a medicine outlet. A visual detector 306 is installed at one end of the central column 304 near the medicine outlet; A probe 102 is provided on the outer wall of the delivery pipe 309 near the front end. The probe 102 is formed by a plurality of plates assembled and connected, and a separation plate 103 is slidably connected between the plates. The outer wall of the plate and the outer wall of the expansion plate 205 are both installed with fixing parts 104, and a retractable rod 105 is hinged between the fixing parts 104 installed on the outer wall of the expansion plate 205 and the fixing parts 104 installed on the outer wall of the plate; A fixed block 312 is fixedly installed inside the solid medicine delivery device 301, a power piece 313 is fixedly connected to the inner wall of the fixed block 312, an output shaft of the power piece 313 is fixedly connected to an auxiliary gear 314, and a power gear 315 is fixedly connected to one end of the center column 304 close to the solid medicine delivery device 301, and the teeth of the power gear 315 mesh with the teeth of the auxiliary gear 314; During operation, when using the applicator, the operator first holds the grip 101, and then applies a proper amount of lubricant on the probe 102, which can reduce the friction on the vaginal mucosa during insertion and reduce the patient's discomfort. Then the applicator is controlled to slowly enter the patient's body. At this time, the expansion plate 205 is controlled to expand outward, and the plate of the probe 102 slides on the separation plate 103. The probe 102 is also controlled by the contraction rod 105 to expand and open the vaginal wall. The first to enter is the visual detector 306, which will feed back the situation inside the uterus to the outside world, and can also detect the position of the probe 102 and the inner wall of the uterus, so that it is convenient to control the insertion depth of the applicator. When the applicator After arriving at the designated position, the medicine is applied according to the patient's needs. If the patient needs solid granular medicine, the power component 313 is started and the medicine is placed into the solid medicine delivery device 301 through the medicine delivery port 302. The power component 313 controls the auxiliary gear 314 to drive the power gear 315 to rotate. The power gear 315 controls the rotation of the control center column 304 to drive the transmission component 305 to rotate. At this time, the solid medicine will be driven by the transmission component 305 to move along the medicine delivery tube 303 until the solid medicine falls from the other end of the medicine delivery tube 303 into the uterus. Through the operation of the solid medicine delivery device 301, the solid medicine is transported to the uterus for application.
[0020] like Figure 7 As shown, the liquid medicine delivery device 307 is located at the rear end of the medicine application device, and the outer wall of the liquid medicine delivery device 307 is provided with a plurality of slots, and the outer wall of each slot is connected with a medicine dish 308, and different types of liquid medicines are stored in each medicine dish 308, and the outer wall of the medicine delivery tube 303 is provided with a plurality of delivery tubes 309, and different types of medicine dishes 308 correspond to the delivery tubes 309 of the medicines respectively; A connecting pipe 310 is clamped between the inside of each group of medicine dishes 308 and the outer wall of the delivery tube 309. A medicine spraying ring 311 is arranged on the outer wall of one end of the medicine delivery tube 303 near the medicine outlet. A plurality of spraying holes are opened on the outer wall of the medicine spraying ring 311. The outer wall of the medicine spraying ring 311 is fixedly connected to the delivery tube 309 and is in conduction with each other. During operation, if the patient needs liquid medicine, the liquid medicine delivery device 307 is equipped with a medicine dish 308 for storing different medicines. At this time, the connecting tube 310 sucks the medicine in the medicine dish 308 into the delivery tube 309. After the medicine in the delivery tube 309 is transferred to the other end, the medicine will enter the medicine spray ring 311. At this moment, the medicine spray ring 311 rotates while spraying the internal medicine on the inner wall of the uterus through the spray port. The thickness of the inner wall of the uterus varies according to individual physical conditions. If the smearing method is used, the medicine application equipment will come into contact with the inner wall of the uterus, and the force of applying the medicine cannot be controlled, which can easily cause great harm to the patient. Through the operation of the medicine spray ring 311, not only the medicine is applied to the inside of the uterus, but also the risk factor of causing damage to the uterus is reduced.
[0021] like Figures 1 to 5 As shown, the expansion assembly 200 includes an expansion disk 201, which is located inside the housing 100. A plurality of expansion slots 202 and limiting slots 203 are provided outside the expansion disk 201, and the expansion slots 202 and the limiting slots 203 are connected to each other. The inner wall of each expansion slot 202 is slidably connected to a limiting pin 204, and an expansion plate 205 is installed at the other end of each limiting pin 204. The outer wall of the expansion disk 201 is provided with a wind blade 206, and the outer wall array of the wind blade 206 is provided with a shifting blade 207, and the shifting blade 207 is in contact with the limiting pin 204; A support frame 208 is fixedly mounted on the inner wall of each expansion plate 205, and the other end of the support frame 208 is slidably connected to the outer wall of the delivery pipe 309. A connecting plate 209 is inserted between the outer walls of each expansion plate 205, and the outer wall of the connecting plate 209 is slidably connected to the inner wall of the expansion plate 205; During operation, after the medication device enters the patient's body, the expansion component 200 is required to expand the vagina and cervix, and the power piece 313 controls the wind blade piece 206 to rotate. When the wind blade piece 206 rotates, the toggle blade 207 will also rotate accordingly. When the outer wall of the toggle blade 207 contacts the limit pin 204, the limit pin 204 will be controlled by the toggle blade 207 to slide on the expansion disk 201. First, the limit pin 204 will slide on the expansion slide groove 202. At this time, the expansion plate 205 will be controlled to expand outward along the trajectory of the expansion slide groove 202. When the limit pin 204 slides to the limit slide groove 203, the limit pin 204 will control the expansion plate 205 to be in an expanded state. When the power piece 313 rotates in the opposite direction, the toggle blade 207 will reversely toggle the limit pin 204 back to the initial position along the original sliding trajectory. Through the operation of the expansion component 200, the effect of expanding the vagina and cervix is achieved.
[0022] Working principle: The shell 100 is an important component connecting the entire device. When the patient uses the medication device, the device will first be inserted into the body. When it reaches the appropriate depth, the expansion component 200 will be used to open the vaginal wall to fully expose the vagina and cervix. This not only facilitates observation of the situation inside the uterus but also makes it easier to apply medication. At this time, the medication can be applied to the inside of the uterus through the medication component 300 according to the internal situation. The medication application device has a solid medication channel and a liquid medication channel. When using the medication application device, the operator first holds the grip 101, and then applies an appropriate amount of lubricant on the probe 102. This can reduce the friction on the vaginal mucosa during insertion and reduce the patient's discomfort. Then the medication application device is controlled to slowly enter the patient's body. When the medication device enters the patient's body, the power piece 313 controls the air blade piece 206 to rotate. When the air blade piece 206 rotates, the toggle blade 207 will also rotate accordingly. When the outer wall of the toggle blade 207 contacts the limiting nail 204, the limiting nail 204 will be controlled by the toggle blade 207 to slide on the expansion disk 201. First, the limiting nail 204 will slide on the expansion slide groove 202. At this time, the expansion plate 205 will be controlled to expand outward along the trajectory of the expansion slide groove 202. When the limiting nail 204 slides to the limiting slide groove 203, the limiting nail 204 will control the expansion plate 205 to be in the expanded state. When the power piece 313 rotates in the opposite direction, the toggle blade 207 will reversely toggle the limiting nail 204 back along the original sliding trajectory. When the uterus reaches the initial position, the visual detector 306 enters first. The visual detector 306 will feed back the situation inside the uterus to the outside world. At the same time, it can also detect the position of the probe 102 and the inner wall of the uterus, so that it is convenient to control the insertion depth of the drug application device. When the drug application device reaches the specified position, the drug is applied according to the drug required by the patient. If the patient needs solid granular drugs, the power member 313 is started at this time, and the drug is placed into the solid drug delivery device 301 through the drug release port 302. The power member 313 controls the auxiliary gear 314 to drive the power gear 315 to rotate. The power gear 315 controls the rotation of the control center column 304 to drive the transmission member 305 to rotate. At this time, the solid drug will be driven by the transmission member 305 along the The drug delivery tube 303 moves until the solid drug falls from the other end of the drug delivery tube 303 into the uterus. If the patient needs liquid drugs, the liquid drug delivery device 307 is equipped with a drug dish 308 for storing different drugs. At this time, the connecting tube 310 sucks the drugs in the drug dish 308 into the delivery tube 309. After the drugs in the delivery tube 309 are transferred to the other end, the drugs will enter the drug spray ring 311. At this moment, the drug spray ring 311 rotates while spraying the internal drugs on the inner wall of the uterus through the spray port. The thickness of the inner wall of the uterus varies according to individual physique. If the smearing method is used, the drug application device will come into contact with the inner wall of the uterus, and the force of applying the drugs cannot be controlled, which can easily cause great harm to the patient.The operation of the liquid drug delivery device 307 not only plays the role of applying medicine to the inside of the uterus, but also reduces the risk of causing damage to the uterus. No matter what state of medicine the patient needs to apply, there is a corresponding structure for applying the medicine. The cooperation of the solid drug delivery device 301 and the liquid drug delivery device 307 can achieve the effect of simultaneously satisfying the application of two different forms of medicine.
[0023] The above shows and describes the basic principles, main features and advantages of the present invention. It should be understood by those skilled in the art that the present invention is not limited to the above embodiments. The above embodiments and descriptions are only for explaining the principles of the present invention. Without departing from the spirit and scope of the present invention, the present invention may have various changes and improvements, which fall within the scope of the present invention. The scope of protection of the present invention is defined by the attached claims and their equivalents.
Claims
1. A uterine wall drug application device, characterized in that: The device comprises a shell (100), an expansion component (200) and a drug application component (300), wherein the shell (100) is located between the expansion component (200) and the drug application component (300), the expansion component (200) is located in the middle section of the drug application device, and the drug application component (300) is located at the rear end of the drug application device; The drug delivery assembly (300) comprises a solid drug delivery device (301) and a liquid drug delivery device (307); A gripping member (101) is fixedly connected between the outer wall of the housing (100) and the outer wall of the liquid medicine delivery device (307).
2. The uterine wall drug application device according to claim 1, characterized in that: The solid drug delivery device (301) is located at the rear end of the drug application device and has a drug delivery port (302) on its outer wall. One end of the solid drug delivery device (301) is fixedly connected to a drug delivery tube (303). A central column (304) is rotatably arranged inside the drug delivery tube (303). A conveying member (305) is fixedly connected to the outer wall of the central column (304). The other end of the drug delivery tube (303) is a drug outlet. A visual detector (306) is installed at one end of the central column (304) close to the medicine outlet.
3. The uterine wall drug application device according to claim 2, characterized in that: A probe (102) is provided on the outer wall of the delivery pipe (309) close to the front end, and the probe (102) is formed by splicing and snap-jointing a plurality of plates, with separation plates (103) being slidably connected between the plates.
4. The uterine wall drug application device according to claim 3, characterized in that: The outer wall of the plate and the outer wall of the expansion plate (205) are both installed with fixing parts (104), and a retractable rod (105) is hinged between the fixing part (104) installed on the outer wall of the expansion plate (205) and the fixing part (104) installed on the outer wall of the plate.
5. The uterine wall drug application device according to claim 4, characterized in that: A fixing block (312) is fixedly installed inside the solid medicine delivery device (301), a power member (313) is fixedly connected to the inner wall of the fixing block (312), an output shaft of the power member (313) is fixedly connected to an auxiliary gear (314), and a power gear (315) is fixedly connected to one end of the center column (304) close to the solid medicine delivery device (301), and the teeth of the power gear (315) are meshed with the teeth of the auxiliary gear (314).
6. The uterine wall drug application device according to claim 5, characterized in that: The liquid medicine delivery device (307) is located at the rear end of the medicine application device. The outer wall of the liquid medicine delivery device (307) is provided with a plurality of slots. The outer wall of each slot is connected with a medicine dish (308). Different types of liquid medicines are stored in each medicine dish (308). The outer wall of the medicine delivery tube (303) is provided with a plurality of delivery tubes (309). Different types of medicine dishes (308) correspond to the delivery tubes (309) of the medicines, respectively.
7. The uterine wall drug application device according to claim 6, characterized in that: A connecting pipe (310) is clamped between the interior of each group of the medicine dishes (308) and the outer wall of the delivery tube (309); a medicine spraying ring (311) is provided on the outer wall of one end of the medicine delivery tube (303) close to the medicine outlet, and a plurality of spraying holes are provided on the outer wall of the medicine spraying ring (311); The outer wall of the medicine spraying ring (311) is fixedly connected to the conveying pipe (309) and is in communication with each other.
8. The uterine wall drug application device according to claim 7, characterized in that: The expansion assembly (200) comprises an expansion disk (201), the expansion disk (201) being located inside the housing (100), and a plurality of expansion slots (202) and limiting slots (203) being provided outside the expansion disk (201), the expansion slots (202) and limiting slots (203) being communicated with each other, the inner wall of each expansion slot (202) being slidably connected to a limiting pin (204), and the other end of each limiting pin (204) being mounted with an expansion plate (205).
9. The uterine wall drug application device according to claim 8, characterized in that: The outer wall of the expansion disk (201) is provided with a wind blade member (206), and the outer wall array of the wind blade member (206) is provided with shifting blades (207), and the shifting blades (207) are in contact with the limiting pins (204).
10. The uterine wall drug application device according to claim 9, characterized in that: A support frame (208) is fixedly mounted on the inner wall of each expansion plate (205), and the other end of the support frame (208) is slidably connected to the outer wall of the delivery pipe (309). A connecting plate (209) is inserted between the outer walls of each expansion plate (205), and the outer wall of the connecting plate (209) is slidably connected to the inner wall of the expansion plate (205).
Citation Information
Patent Citations
Uterine wall medicine applying equipment for gynecology department
CN113332579A